SecBot SecBot
8-K ·Filed Mar 31, 2026

JUSHF

Jushi Holdings Inc.
MIXED
Impact 6/10
Horizonweeks Processed7mo ago SEC0001171843-26-002091
earnings-rerun-backfill
Actionable Insight ◆ Mixed

Monitor Q1 2026 for signs of margin sustainability and debt refinancing benefits; the 74% Adjusted EBITDA growth and Virginia adult-use market entry (2027) could drive long-term value despite the EPS miss.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
JUSHF ▼ -7.61% at T+60d
NEUTRAL call -7.61% · α vs SPY -20.99% · entry $0.5190 → $0.4795
Entry = T+0 close
Mar 31, 2026
via day close
T+1d
+4.05%
call +4.05% · α +3.97%
$0.5400
settled 7mo ago
T+5d
+2.12%
call +2.12% · α -1.65%
$0.5300
settled 7mo ago
T+20d
-5.59%
call -5.59% · α -15.31%
$0.4900
settled 6mo ago
T+60d
-7.61%
call -7.61% · α -20.99%
$0.4795
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Jushi Holdings reported Q4 2025 revenue of $68.3 million (3.8% YoY growth) and a net loss of $15.6 million, missing EPS consensus of $-0.06 with actual of $-0.08. Adjusted EBITDA surged 74% YoY to $13.9 million, driven by operational improvements and new store openings. The company refinanced $132.3 million in debt into a $160 million term loan due 2029, extending maturities and strengthening liquidity.

Key Financial Metrics

EPS
−$0.08
est −$0.06 · -33.3%
Revenue
$68.3M
est $66.8M · +2.3% · +3.8% YoY
Rating
miss
Gross Margin
41.9%

Key Facts

  • Q4 2025 revenue: $68.3 million (3.8% YoY growth), missing $66.8M consensus
  • EPS: $-0.08 vs. $-0.06 estimate (33.3% miss)
  • Adjusted EBITDA: $13.9 million (74% YoY growth), margin improved to 20.4%
  • Gross profit margin: 41.9% (up from 38.6% YoY)
  • Refinanced $132.3 million in debt into $160 million 12.5% secured term loan due 2029
  • Ended year with 42 dispensaries (8 new openings), Jushi-branded sales at 58% of retail revenue

Financial Impact

Revenue grew 3.8% YoY but missed estimates by $1.5 million; net loss widened to $15.6 million despite 74% Adjusted EBITDA growth; full-year revenue up 2.1% to $262.9 million but gross margin declined 3.7% YoY

revenueepsebitdagross_margindebt

Risk Factors

  • Net loss widened to $15.6 million despite revenue growth
  • Full-year gross margin declined 3.7% YoY to 43.4% due to pricing pressure
  • High debt load with $193.1 million subject to scheduled repayments

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-002091
Document: f8k_033126.htm0001171843-26-002091
Document: 0001171843-26-002091-index-headers.html0001171843-26-002091
Document: 0001171843-26-002091-index.html0001171843-26-002091
Document: 0001171843-26-002091.txt0001171843-26-002091
8-K Data (Synthetic)0001171843-26-002091
5 reports for JUSHF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for JUSHF — sortable, filterable
TypeNow
Aug 4, 2026
12w ago
EFFECT
BEARISH ★ 5/10
$0.4520 $0.4223▲ +6.57%▲ +6.47%—
Jun 24, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$0.4810 $0.4760▼ −1.04%▼ −2.47%—
Apr 24, 2026
26w ago
8-K / DEFA14A
NEUTRAL ★ 5/10
$0.5100 $0.5200▲ +1.96%▲ +1.05%—
Apr 14, 2026
28w ago
10-K/A
NEUTRAL ★ 4/10
$0.5500 $0.6200▲ +12.73%▲ +11.09%—
Mar 31, 2026
30w ago
8-K
MIXED ★ 6/10
$0.5190 $0.5300▲ +2.12%▼ −1.65%—
Showing 5 of 5

US Market Status

Market Closed — Opens Wed (16h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026